कृपया अन्य खोज का प्रयास करें
Mainz Biomed N.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics. It offers ColoAlert, a colorectal cancer screening stool-based deoxyribonucleic acid test; and PancAlert, a product candidate for a pancreatic cancer screening test. The company has a research collaboration with Microba Life Sciences to discover and develop novel therapeutics for major diseases. The company was founded in 2008 and is based in Mainz, Germany.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Soren Thestrup-Nielsen | - | 2021 | Member of Strategic Advisory Board |
Rainer Metzger | - | 2022 | Member of Strategic Advisory Board |
D. Kim Turgeon | - | 2022 | Member of Medical Advisory Board |
Michele Pedrocchi | - | 2022 | Member of Strategic Advisory Board |
Douglas K. Rex | - | 2022 | Member of Medical Advisory Board |
Timothy Cragin Wang | - | 2022 | Member of Medical Advisory Board |
Alberto Libanori | 33 | 2021 | Independent Non-Executive Director |
Hans Johan Hekland | 65 | 2021 | Independent Non-Executive Director |
Nicole Holden | 49 | 2021 | Independent Non-Executive Director |
Heinrich Dreismann | 70 | 2021 | Independent Non-Executive Chairman |
Gregory J. Tibbitts | 56 | 2022 | Independent Non-Executive Director |
Nicole Holden | 50 | 2021 | Independent Non-Executive Director |
Guido Baechler | 59 | 2021 | CEO & Executive Director |
Moritz Eidens | 40 | 2008 | Chief Science Officer & Executive Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है